HESI RN
HESI RN Pharmacology 106a Questions
Extract:
Question 1 of 5
The nurse discontinues the client's patient-controlled analgesia (PCA). Which statement about eye drops is correct?
Correct Answer: A
Rationale: The question context is unclear, as PCA discontinuation is unrelated to eye drops. Assuming it refers to a prior topic, choice A is plausible for certain eye drops (e.g., those increasing aqueous humor), but B is more specific to miotics like pilocarpine. Without context, A is marked correct per the data, though clarification is needed.
Question 2 of 5
The nurse discontinues the client's patient-controlled analgesia (PCA). Which statement about eye drops is correct?
Correct Answer: A
Rationale: The question context is unclear, as PCA discontinuation is unrelated to eye drops. Assuming it refers to a prior topic, choice A is plausible for certain eye drops (e.g., those increasing aqueous humor), but B is more specific to miotics like pilocarpine. Without context, A is marked correct per the data, though clarification is needed.
Question 3 of 5
Prior to administering an oral dose of methylprednisolone, the nurse determines the client's serum total calcium level is 5.5 mg/dL (1.4 mmol/L). Which action is most important for the nurse to take?
Correct Answer: A
Rationale: A calcium level of 5.5 mg/dL indicates severe hypocalcemia, requiring immediate provider notification for evaluation. Tapering, dietary teaching, or milk administration are secondary to addressing this critical imbalance.
Question 4 of 5
During a home visit, the nurse assesses a client with Alzheimer's disease who recently started a new prescription for rivastigmine. The caregiver reports that the client seems to be thinking more clearly but is not sleeping well at night. Which action should the nurse take?
Correct Answer: A
Rationale: Insomnia is a common, often temporary side effect of rivastigmine. Explaining this reassures the caregiver. Rivastigmine is for cognition, not sleep, and withholding or increasing the dose is inappropriate without provider guidance.
Question 5 of 5
A client with chronic kidney disease (CKD) is receiving calcium acetate 667 mg PO. A decrease in which blood value indicates to the nurse that the medication is having the desired effect?
Correct Answer: C
Rationale: Calcium acetate binds phosphate in CKD, reducing serum phosphate levels, which indicates effectiveness. Calcium, potassium, and pH are not primary targets.